Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 3,460 | 1,374 | 6,808 | 1,293 | 1,216 |
| Gross Profit | 3,460 | 1,374 | 6,808 | 1,293 | 1,216 |
| Operating Expenses | 43,603 | 45,775 | 32,781 | 30,926 | 29,015 |
| Operating Income | -40,143 | -44,401 | -25,973 | -29,633 | -27,799 |
| Other Income | 298 | 146 | -416 | -3,869 | -4,755 |
| Pre-tax Income | -39,845 | -44,255 | -26,389 | -33,502 | -32,554 |
| Net Income Continuous | -39,845 | -44,255 | -26,413 | -33,502 | -32,554 |
| Net Income | $-39,845 | $-44,255 | $-26,413 | $-33,502 | $-32,554 |
| EPS Basic Total Ops | -1.50 | -1.58 | -0.93 | -1.18 | -1.15 |
| EPS Basic Continuous Ops | -1.50 | -1.58 | -0.92 | -1.18 | -1.15 |
| EPS Diluted Total Ops | -1.50 | -1.58 | -0.93 | -1.18 | -1.15 |
| EPS Diluted Continuous Ops | -1.50 | -1.58 | -0.92 | -1.18 | -1.15 |
| EPS Diluted Before Non-Recurring Items | -1.50 | -1.58 | -0.93 | N/A | N/A |
| EBITDA(a) | $-41,739 | $-45,999 | $-27,090 | $-29,832 | $-27,389 |